Dr. Yamada previously served as the CMO and chief scientific officer at Takeda Pharmaceuticals. He also has experience as the chief of the gastroenterology division at the University of Michigan at Ann Arbor.
During his career, Dr. Yamda also served as the president of the Bill & Melinda Gates Foundation Global Health Program in Seattle.
In addition to his role with Frazier, he serves on the board of directors for the Clinton Health Access Initiative.
Frazier provides growth capital to healthcare companies.
More articles on gastroenterology:
Skiff Medical Center’s endoscopy suite acquires FUJIFILM technology
EndoChoice refinances debt
Dr. Sheetal Sharma joins Mercy Clinic Gastroenterology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
